KindlyMD’s Q3 earnings delay stems from complexities in accounting for its Nakamoto merger, leading to a nearly 10% stock drop on Monday and a projected $59 million loss on the acquisition. The company cited unreasonable effort to file on time, highlighting ongoing financial turbulence in the crypto-integrated healthcare space. Stock plunged 10% post-delay announcement: Shares
